EQ-5D health utility gains with once-weekly semaglutide 2.4 mg in people with MASH and F2/F3 fibrosis: An analysis of ESSENCE. // JHEP Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2589555926002648?dgcid=rss_sd_all
EQ-5D health utility gains with once-weekly semaglutide 2.4 mg in people with MASH and F2/F3 fibrosis: An analysis of ESSENCE. JHEP Reports. https://www.sciencedirect.com/science/article/pii/S2589555926002648?dgcid=rss_sd_all
“EQ-5D health utility gains with once-weekly semaglutide 2.4 mg in people with MASH and F2/F3 fibrosis: An analysis of ESSENCE.” JHEP Reports.
@article{article51268,
title = {EQ-5D health utility gains with once-weekly semaglutide 2.4 mg in people with MASH and F2/F3 fibrosis: An analysis of ESSENCE},
journal = {JHEP Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2589555926002648?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...